Therapy with ASA, P2Y12 inhibitor, and statin at discharge following PCI in eligible patients

INACTIVE REVIEW: This measure review is older than five years.

Patients undergoing PCI who receive prescriptions for all medications (ASA, P2Y12 and statins) for which they are eligible for at discharge

Date Reviewed: November 7, 2015

Measure Info

NQF 0964 NQF Endorsed
Measure Type
Measure Steward
American College of Cardiology
Clinical Topic Area
Interventional Cardiology

Care Setting
Data Source

ACP supports this measure because it considers pre-existing medications, includes appropriate exclusion criteria for patients without stents, and its use of electronic medical records reduces provider burden.